Search
Lepzacitinib
go.drugbank.com/drugs/DB21646InvestigationalLepzacitinib has a monoisotopic molecular weight of 355.16 Da.
Luvometinib
go.drugbank.com/drugs/DB21696InvestigationalLuvometinib has a monoisotopic molecular weight of 665.04 Da.
Pebezertinib
go.drugbank.com/drugs/DB21705InvestigationalPebezertinib has a monoisotopic molecular weight of 497.16 Da.
Inlexisertib
go.drugbank.com/drugs/DB21713InvestigationalInlexisertib has a monoisotopic molecular weight of 535.29 Da.
ARC183
go.drugbank.com/drugs/DB05124ExperimentalThe key advantage of ARC183 compared to other thrombin inhibitors is its rapid onset of action and short half-life, giving it the potential to be an ideal agent for medical procedures that require rapid
Nivolumab
go.drugbank.com/drugs/DB09035ApprovedInvestigationalNivolumab is a fully human IgG4 antibody targeting the immune checkpoint programmed death receptor-1 (PD-1). This antibody was produced entirely in mice and grafted onto human kappa and IgG4 Fc region with the mutation S228P for addition...
DTS-201
go.drugbank.com/drugs/DB06071ExperimentalDTS-201 is a prodrug of doxorubicin, a widely used anti-cancer drug that Diatos intends to develop for the treatment of various solid tumors. It is activated in the tumor environment. DTS-201 may be suitable for the treatment of many typ...
GR270773
go.drugbank.com/drugs/DB06427InvestigationalGR270773, was investigated in two clinical trials for its potential to treat sepsis: NCT00158769 (completed, comparing the effects of infusion between healthy adults and those with damaged livers) and NCT00089986 (completed with results,...